Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing

BMC Genomics

Volumn 16, Issue 1, 2015, Pages

  Van den Hoecke, Silvie ^a,b   Verhelst, Judith ^a,b   Vuylsteke, Marnik ^c   Saelens, Xavier ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GNOMIXX bvba   (Belgium)

Author keywords

Illumina MiSeq; Influenza virus; Ion Torrent PGM; Next generation sequencing; Quasispecies; RT PCR

Indexed keywords

GENOMIC RNA; HEMAGGLUTININ; PLASMID DNA; VIRUS DNA;

AMINO ACID SUBSTITUTION; ANALYTICAL ERROR; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENETIC ANALYZER; GENETIC VARIABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; INDEL MUTATION; INFLUENZA VIRUS A; NEXT GENERATION SEQUENCING; NONHUMAN; PROCESS OPTIMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; TURNAROUND TIME; VIROGENESIS; VIRUS GENOME; VIRUS MUTANT; WILD TYPE; GENETICS; INFLUENZA; INFLUENZA A VIRUS; PROCEDURES; VIROLOGY;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

GENETIC VARIATION; GENOME, VIRAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN;

EID: 84924311018     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/s12864-015-1284-z     Document Type: Article

References (79)

1. Eigen M. Molecular self-organization and the early stages of evolution. Experientia. 1971;27(11):149-212.
2. Eigen M, Schuster P. The hypercycle. A principle of natural self-organization. Part A: emergence of the hypercycle. Naturwissenschaften. 1977;64(11):541-65.
3. Eigen M. Viral quasispecies. Sci Am. 1993;269(1):42-9.
4. Eigen M. On the nature of virus quasispecies. Trends Microbiol. 1996;4(6):216-8.
5. Lauring AS, Andino R. Quasispecies theory and the behavior of RNA viruses. PLoS Pathog. 2010;6(7):e1001005.
6. Domingo E, Martinez-Salas E, Sobrino F, de la Torre JC, Portela A, Ortin J, et al. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance-a review. Gene. 1985;40(1):1-8.
7. Nowak MA. What is a quasispecies? Trends Ecol Evol. 1992;7(4):118-21.
8. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature. 2006;439(7074):344-8.
9. Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, et al. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science. 2009;326(5953):734-6.
10. Schmolke M, Garcia-Sastre A. Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol. 2010;12(7):873-80.
11. Wright P, Webster R. In: Knipe D, Howley P, editors. Fields Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1533-79.
12. Nobusawa E, Sato K. Comparison of the mutation rates of human influenza A and B viruses. J Virol. 2006;80(7):3675-8.
13. Sanjuan R, Nebot MR, Chirico N, Mansky LM, Belshaw R. Viral mutation rates. J Virol. 2010;84(19):9733-48.
14. Parvin JD, Moscona A, Pan WT, Leider JM, Palese P. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J Virol. 1986;59(2):377-83.
15. Baz M, Abed Y, McDonald J, Boivin G. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis. 2006;43(12):1555-61.
16. Robertson JS, Nicolson C, Bootman JS, Major D, Robertson EW, Wood JM. Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus. J Gen Virol. 1991;72(Pt 11):2671-7.
17. Iqbal M, Xiao H, Baillie G, Warry A, Essen SC, Londt B, et al. Within-host variation of avian influenza viruses. Philos Trans R Soc Lond Ser B Biol Sci. 2009;364(1530):2739-47.
18. Murcia PR, Baillie GJ, Daly J, Elton D, Jervis C, Mumford JA, et al. Intra- and interhost evolutionary dynamics of equine influenza virus. J Virol. 2010;84(14):6943-54.
19. Junemann S, Sedlazeck FJ, Prior K, Albersmeier A, John U, Kalinowski J, et al. Updating benchtop sequencing performance comparison. Nat Biotechnol. 2013;31(4):294-6.
20. Loman NJ, Misra RV, Dallman TJ, Constantinidou C, Gharbia SE, Wain J, et al. Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol. 2012;30(5):434-9.
21. Quail MA, Smith M, Coupland P, Otto TD, Harris SR, Connor TR, et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent. Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics. 2012;13:341.
22. Robasky K, Lewis NE, Church GM. The role of replicates for error mitigation in next-generation sequencing. Nat Rev Genet. 2014;15(1):56-62.
23. Glenn TC. Field guide to next-generation DNA sequencers. Mol Ecol Resour. 2011;11(5):759-69.
24. Croville G, Soubies SM, Barbieri J, Klopp C, Mariette J, Bouchez O, et al. Field monitoring of avian influenza viruses: whole-genome sequencing and tracking of neuraminidase evolution using 454 pyrosequencing. J Clin Microbiol. 2012;50(9):2881-7.
25. Hoper D, Hoffmann B, Beer M. A comprehensive deep sequencing strategy for full-length genomes of influenza A. PLoS One. 2011;6(4):e19075.
26. Lin Z, Farooqui A, Li G, Wong GK, Mason AL, Banner D, et al. Next-generation sequencing and bioinformatic approaches to detect and analyze influenza virus in ferrets. J Infect Dev Ctries. 2014;8(4):498-509.
27. Rutvisuttinunt W, Chinnawirotpisan P, Simasathien S, Shrestha SK, Yoon IK, Klungthong C, et al. Simultaneous and complete genome sequencing of influenza A and B with high coverage by Illumina MiSeq Platform. J Virol Methods. 2013;193(2):394-404.
28. Wilker PR, Dinis JM, Starrett G, Imai M, Hatta M, Nelson CW, et al. Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses. Nat Commun. 2013;4:2636.
29. Zhou B, Lin X, Wang W, Halpin RA, Bera J, Stockwell TB, et al. Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics. J Clin Microbiol. 2014;52(5):1330-7.
30. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A. 2000;97(11):6108-13.
31. Hoffmann E, Krauss S, Perez D, Webby R, Webster RG. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine. 2002;20(25-26):3165-70.
32. Del Fabbro C, Scalabrin S, Morgante M, Giorgi FM. An extensive evaluation of read trimming effects on Illumina NGS data analysis. PLoS One. 2013;8(12):e85024.
33. Dohm JC, Lottaz C, Borodina T, Himmelbauer H. Substantial biases in ultra-short read data sets from high-throughput DNA sequencing. Nucleic Acids Res. 2008;36(16):e105.
34. Ross MG, Russ C, Costello M, Hollinger A, Lennon NJ, Hegarty R, et al. Characterizing and measuring bias in sequence data. Genome Biol. 2013;14(5):R51.
35. Goryshin IY, Miller JA, Kil YV, Lanzov VA, Reznikoff WS. Tn5/IS50 target recognition. Proc Natl Acad Sci U S A. 1998;95(18):10716-21.
36. Minoche AE, Dohm JC, Himmelbauer H. Evaluation of genomic high-throughput sequencing data generated on Illumina HiSeq and genome analyzer systems. Genome Biol. 2011;12(11):R112.
37. Agresti A, Coull BA. Approximate is better than "exact" for interval estimation of binomial proportions. Am Stat. 1998;52(2):119-26.
38. Nakamura K, Oshima T, Morimoto T, Ikeda S, Yoshikawa H, Shiwa Y, et al. Sequence-specific error profile of Illumina sequencers. Nucleic Acids Res. 2011;39(13):e90.
39. Allhoff M, Schonhuth A, Martin M, Costa IG, Rahmann S, Marschall T. Discovering motifs that induce sequencing errors. BMC Bioinformatics. 2013;14 Suppl 5:S1.
40. Altshuler D, Pollara VJ, Cowles CR, Van Etten WJ, Baldwin J, Linton L, et al. An SNP map of the human genome generated by reduced representation shotgun sequencing. Nature. 2000;407(6803):513-6.
41. Adeyefa CA, Quayle K, McCauley JW. A rapid method for the analysis of influenza virus genes: application to the reassortment of equine influenza virus genes. Virus Res. 1994;32(3):391-9.
42. Watson SJ, Welkers MR, Depledge DP, Coulter E, Breuer JM, de Jong MD, et al. Viral population analysis and minority-variant detection using short read next-generation sequencing. Philos Trans R Soc Lond Ser B Biol Sci. 2013;368(1614):20120205.
43. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, Kawaoka Y, et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza A viruses. J Virol. 2009;83(19):10309-13.
44. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008;18(5):821-9.
45. Compeau PE, Pevzner PA, Tesler G. How to apply de Bruijn graphs to genome assembly. Nat Biotechnol. 2011;29(11):987-91.
46. Adey A, Morrison HG, Asan, Xun X, Kitzman JO, Turner EH, et al. Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome Biol. 2010;11(12):R119.
47. Dreger M, Leung BW, Brownlee GG, Deng T. A quantitative strategy to detect changes in accessibility of protein regions to chemical modification on heterodimerization. Protein Sci. 2009;18(7):1448-58.
48. Gen F, Yamada S, Kato K, Akashi H, Kawaoka Y, Horimoto T. Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice. Arch Virol. 2013;158(5):1003-11.
49. Chen LM, Blixt O, Stevens J, Lipatov AS, Davis CT, Collins BE, et al. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology. 2012;422(1):105-13.
50. Nobusawa E, Ishihara H, Morishita T, Sato K, Nakajima K. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology. 2000;278(2):587-96.
51. Kong W, Liu L, Wang Y, Gao H, Wei K, Sun H, et al. Hemagglutinin mutation D222N of the 2009 pandemic H1N1 influenza virus alters receptor specificity without affecting virulence in mice. Virus Res. 2014;189:79-86.
52. Mochalova L, Gambaryan A, Romanova J, Tuzikov A, Chinarev A, Katinger D, et al. Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology. 2003;313(2):473-80.
53. Zhang W, Shi Y, Qi J, Gao F, Li Q, Fan Z, et al. Molecular basis of the receptor binding specificity switch of the hemagglutinins from both the 1918 and 2009 pandemic influenza A viruses by a D225G substitution. J Virol. 2013;87(10):5949-58.
54. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell. 1982;31(2 Pt 1):417-27.
55. Biswas SK, Boutz PL, Nayak DP. Influenza virus nucleoprotein interacts with influenza virus polymerase proteins. J Virol. 1998;72(7):5493-501.
56. Elton D, Medcalf E, Bishop K, Digard P. Oligomerization of the influenza virus nucleoprotein: identification of positive and negative sequence elements. Virology. 1999;260(1):190-200.
57. Rimmelzwaan GF, Kreijtz JH, Bodewes R, Fouchier RA, Osterhaus AD. Influenza virus CTL epitopes, remarkably conserved and remarkably variable. Vaccine. 2009;27(45):6363-5.
58. Dias A, Bouvier D, Crepin T, McCarthy AA, Hart DJ, Baudin F, et al. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature. 2009;458(7240):914-8.
59. Yuan P, Bartlam M, Lou Z, Chen S, Zhou J, He X, et al. Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature. 2009;458(7240):909-13.
60. Obayashi E, Yoshida H, Kawai F, Shibayama N, Kawaguchi A, Nagata K, et al. The structural basis for an essential subunit interaction in influenza virus RNA polymerase. Nature. 2008;454(7208):1127-31.
61. Myers JL, Wetzel KS, Linderman SL, Li Y, Sullivan CB, Hensley SE. Compensatory hemagglutinin mutations alter antigenic properties of influenza viruses. J Virol. 2013;87(20):11168-72.
62. Skehel JJ, Waterfield MD. Studies on the primary structure of the influenza virus hemagglutinin. Proc Natl Acad Sci U S A. 1975;72(1):93-7.
63. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, Wang ML, et al. Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell. 1985;40(2):431-9.
64. Cross KJ, Wharton SA, Skehel JJ, Wiley DC, Steinhauer DA. Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics. EMBO J. 2001;20(16):4432-42.
65. Roedig JV, Rapp E, Hoper D, Genzel Y, Reichl U. Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin. PLoS One. 2011;6(12):e27989.
66. Xu X, Zhu X, Dwek RA, Stevens J, Wilson IA. Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J Virol. 2008;82(21):10493-501.
67. Man S, Newberg MH, Crotzer VL, Luckey CJ, Williams NS, Chen Y, et al. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice. Int Immunol. 1995;7(4):597-605.
68. Qian XY, Alonso-Caplen F, Krug RM. Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. J Virol. 1994;68(4):2433-41.
69. Neumann G, Hughes MT, Kawaoka Y. Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J. 2000;19(24):6751-8.
70. Ellebedy AH, Webby RJ. Influenza vaccines. Vaccine. 2009;27 Suppl 4:D65-8.
71. Baillie GJ, Galiano M, Agapow PM, Myers R, Chiam R, Gall A, et al. Evolutionary dynamics of local pandemic H1N1/2009 influenza virus lineages revealed by whole-genome analysis. J Virol. 2012;86(1):11-8.
72. Lam HY, Clark MJ, Chen R, Chen R, Natsoulis G, O'Huallachain M, et al. Performance comparison of whole-genome sequencing platforms. Nat Biotechnol. 2012;30(1):78-82.
73. Ratan A, Miller W, Guillory J, Stinson J, Seshagiri S, Schuster SC. Comparison of sequencing platforms for single nucleotide variant calls in a human sample. PLoS One. 2013;8(2):e55089.
74. Lee CY, Kam YW, Fric J, Malleret B, Koh EG, Prakash C, et al. Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants. PLoS Pathog. 2011;7(12):e1002390.
75. Brooke CB, Ince WL, Wrammert J, Ahmed R, Wilson PC, Bennink JR, et al. Most influenza A virions fail to express at least one essential viral protein. J Virol. 2013;87(6):3155-62.
76. Gambaryan AS, Robertson JS, Matrosovich MN. Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology. 1999;258(2):232-9.
77. Li Z, Watanabe T, Hatta M, Watanabe S, Nanbo A, Ozawa M, et al. Mutational analysis of conserved amino acids in the influenza A virus nucleoprotein. J Virol. 2009;83(9):4153-62.
78. de Wit E, Spronken MI, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res. 2004;103(1-2):155-61.
79. Lycett S, McLeish NJ, Robertson C, Carman W, Baillie G, McMenamin J, et al. Origin and fate of A/H1N1 influenza in Scotland during 2009. The Journal of General Virology. 2012;93(Pt 6):1253-60.